CVE-2017-20221Telesquare SKT LTE Router SDT-CS3B1 version 1.2.0 contains a cross-site request forgery vulnerability that allows authenticated attackers to execute arbitrary system commands by exploiting missing re…
Updated under an hour ago ()
Does this affect you?
It affects telesquare sdt-cs3b1_firmware. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
Telesquare SKT LTE Router SDT-CS3B1 version 1.2.0 contains a cross-site request forgery vulnerability that allows authenticated attackers to execute arbitrary system commands by exploiting missing request validation. Attackers can craft malicious web pages that perform administrative actions when visited by logged-in users, enabling command execution with router privileges.
- CVSS
- 3.5 LOW (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N
- Weakness (CWE)
- CWE-352
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Analyzed
- Record last updated
- Jun 17, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
telesquare sdt-cs3b1_firmware telesquare:sdt-cs3b1_firmware | 1.2.0 | NVD |
References
- https://cxsecurity.com/issue/WLB-2017120299issue-tracking
- https://exchange.xforce.ibmcloud.com/vulnerabilities/136839third-party-advisory
- https://packetstormsecurity.com/files/145550exploit, third-party-advisory
- https://www.exploit-db.com/exploits/43400/exploit, vdb-entry
- https://www.vulncheck.com/advisories/telesquare-skt-lte-router-sdt-cs3b1-csrf-system-command-executionthird-party-advisory
- https://www.zeroscience.mk/en/vulnerabilities/ZSL-2017-5443.phpexploit, third-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.